pyrroles has been researched along with Rhabdomyolysis in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (6.56) | 18.2507 |
| 2000's | 37 (60.66) | 29.6817 |
| 2010's | 20 (32.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eshraghian, A; Kamyab, AA | 1 |
| Panchangam, V | 1 |
| Horoshko, OM; Zamors'kyĭ, II; Zeleniuk, VH | 1 |
| Hunter, ML; Mahvan, TD; Mlodinow, SG; Onysko, MK; Vandiver, JW | 1 |
| Fabiny, A | 1 |
| Al-Khayatt, MS; Brull, DJ; Campbell, VL; O'Mahony, C | 1 |
| Glueck, CJ; Goldenberg, N; Khan, NA; Rawal, B; Wang, P; Yeramaneni, S | 1 |
| Abel, T; Fehér, J | 1 |
| Antoine, JC; Estour, B; Germain, N; Khalfallah, Y; Leca, V; Vergely, N | 1 |
| Akiyoshi, T; Anami, S; Matsuyama, K; Matzno, S; Nakabayashi, T; Nishiguchi, T | 1 |
| Bate, A; Edwards, IR; Hägg, S; Strandell, J | 1 |
| Cecere, FL; Di Costanzo, F; Doni, L; Moscetti, L; Padalino, D; Ruggeri, EM | 1 |
| Clarkson, MR; Conlon, PJ; Leavey, SF; Magee, CN; Medani, SA | 1 |
| Anetseder, M; Hager, M; Metterlein, T; Roewer, N; Schuster, F; Tadda, L | 1 |
| Bonbled, F; Hantson, P; Huberlant, V; Montiel, V; Vincent, MF | 1 |
| Almond, A; Donaldson, K; Isles, C; Robertson, S; Teckchandani, S | 1 |
| Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE | 1 |
| Åsberg, A; Bogsrud, MP; Hermann, M; Retterstøl, K; Skottheim, IB | 1 |
| Abraham, G; Gnanaraj, A; Sankardas, MA; Victor, SM | 1 |
| Bhome, R; Penn, H | 1 |
| Fenech, ME; Mackay, JW; Myint, KS | 1 |
| Cannon, CS | 1 |
| Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S | 1 |
| Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM | 1 |
| Enache, I; Garrouste, C; Heng, AE; Kaysi, S; Philipponnet, C; Tiple, A | 1 |
| Lewin, JJ; Nappi, JM; Taylor, MH | 1 |
| Bernstein, D; Chin, C; Gamberg, P; Luikart, H; Miller, J | 1 |
| Bendahan, D; Bernard, V; Cozzone, PJ; Figarella-Branger, D; Guis, S; Kozak-Ribbens, G; Lando, A; Mattei, JP; Pellissier, JF; Treffouret, S | 1 |
| Bokhart, GH; Jones, RJ; Sipe, BE | 1 |
| Gill, MJ; Mah Ming, JB | 1 |
| Chan, KH; Chau, E; Lai, KC; Wai-Hung Shek, T; Wong, WM | 1 |
| Das, V; Shrivastava, R; Singh, S | 1 |
| Karch, AM | 1 |
| Bäcklund, T; Kahri, J; Kivistö, KT; Valkonen, M; Vuoristo, M | 1 |
| Satish, B; Unnikrishnan, D | 1 |
| Ravnskov, U; Rosch, PJ; Sutter, MC | 1 |
| McKenney, JM | 1 |
| Phillips, PS | 1 |
| Ho, L; Levidiotis, V; Lim, AK | 1 |
| Edwards, C; Gladding, PA; Kerr, A | 1 |
| Chiesa, G; Cippone, V; Conte Camerino, D; De Luca, A; De Vito, D; Didonna, MP; Frigeri, A; Nicchia, GP; Pierno, S; Pisoni, M; Rizzo, C; Scanziani, E; Sirtori, C; Svelto, M | 1 |
| Boyd, IW; O'Shea, JM; Ronaldson, KJ | 1 |
| Evans, M; Golomb, B | 1 |
| Alsheikh-Ali, AA; Karas, RH | 1 |
| Jose, J; Saravu, K; Shastry, BA | 1 |
| Rosenberg, L; Uretsky, S | 1 |
| Amado Señaris, JA; García Unzueta, MT; Otero Martínez, M; Piedra León, M | 1 |
| Dal Pan, G; McAdams, M; Staffa, J | 1 |
| Connor, WE; Duell, PB; Illingworth, DR | 1 |
| Dietz, BL; Oberg, KC | 1 |
| Balog, DL; Cheigh, JS; Maltz, HC | 1 |
| Chik, G; Christ, ER; Crook, MA; Lumb, PJ; Semra, Y; Wierzbicki, AS | 1 |
| El Menjawi, I; Fladerer, P; Krause, R; Pohanka, E; Wenisch, C | 1 |
| Castro, JG; Gutierrez, L | 1 |
| Bellosta, S; Corsini, A; Paoletti, R | 1 |
2 review(s) available for pyrroles and Rhabdomyolysis
| Article | Year |
|---|---|
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
Topics: Allylamine; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; Niacin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2005 |
Pharmacological interactions of statins.
Topics: Atorvastatin; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Tolerance; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Muscular Diseases; Pyrroles; Rhabdomyolysis | 2002 |
2 trial(s) available for pyrroles and Rhabdomyolysis
| Article | Year |
|---|---|
Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Topics: Atorvastatin; Cholesterol, LDL; Creatine Kinase; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Pravastatin; Prospective Studies; Pyrimidines; Pyrroles; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2009 |
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Creatine Kinase; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pyrroles; Rhabdomyolysis; Sensitivity and Specificity | 2011 |
57 other study(ies) available for pyrroles and Rhabdomyolysis
| Article | Year |
|---|---|
Rhabdomyolysis developing secondary to atorvastatin therapy in a patient with liver cirrhosis.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Liver Cirrhosis; Pyrroles; Rhabdomyolysis | 2013 |
Statin-associated acute interstitial nephritis and rhabdomyolysis.
Topics: Acute Kidney Injury; Atorvastatin; Glucocorticoids; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nephritis, Interstitial; Prednisolone; Pyrroles; Renal Dialysis; Rhabdomyolysis; Time Factors; Treatment Outcome | 2014 |
[Renoprotective efficacy of different doses of statins in experimental acute renal failure].
Topics: Acute Kidney Injury; Administration, Topical; Animals; Atorvastatin; Creatine Kinase; Diuresis; Glomerular Filtration Rate; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lovastatin; Pyrroles; Rats; Rhabdomyolysis; Simvastatin; Stomach; Urodynamics | 2014 |
Statin adverse effects: sorting out the evidence.
Topics: Atorvastatin; Clinical Trials as Topic; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Practice; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Outcome Assessment, Health Care; Practice Guidelines as Topic; Pyrroles; Rhabdomyolysis; Risk Adjustment; Ubiquinone; Vitamins | 2014 |
Ask the doctor. I am 61 and had been on atorvastatin for 10 years with no problems. Recently, I've had disabling muscle pain with both the generic atorvastatin and the brand-name version, Lipitor. My doctor says that I can no longer take statin drugs.
Topics: Anticholesteremic Agents; Atorvastatin; Female; Health Behavior; Heptanoic Acids; Humans; Middle Aged; Muscle, Skeletal; Pyrroles; Rhabdomyolysis; Stroke | 2014 |
Rhabdomyolysis with atorvastatin and fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteomyelitis; Pyrroles; Rhabdomyolysis | 2008 |
[Statin therapy and muscle disorders].
Topics: Atorvastatin; Biological Availability; Cytochrome P-450 Enzyme System; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Muscle, Skeletal; Muscular Diseases; Pravastatin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2009 |
[Metabolic rhabdomyolysis during statin therapy].
Topics: Atorvastatin; Carnitine O-Palmitoyltransferase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyridines; Pyrroles; Rhabdomyolysis | 2009 |
Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.
Topics: Alendronate; Animals; Apoptosis; Atorvastatin; Bone Density Conservation Agents; Caspases; Cell Line; Diphosphonates; DNA Fragmentation; Drug Synergism; Enzyme Activation; Etidronic Acid; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myoblasts, Skeletal; Pyrroles; Rats; Rhabdomyolysis; Risedronic Acid | 2009 |
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Atorvastatin; Azithromycin; Databases, Factual; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Pravastatin; Pyridines; Pyrroles; Rhabdomyolysis; Simvastatin | 2009 |
Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Pyrroles; Renal Dialysis; Rhabdomyolysis; Sunitinib; Treatment Outcome | 2010 |
Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Follow-Up Studies; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteomyelitis; Pyrroles; Rhabdomyolysis; Severity of Illness Index | 2010 |
Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals.
Topics: Animals; Atorvastatin; Biopsy; Calcium; Electric Stimulation; Female; Gemfibrozil; Genotype; Heptanoic Acids; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Isometric Contraction; Male; Malignant Hyperthermia; Muscle, Skeletal; Phenotype; Pyrroles; Rhabdomyolysis; Simvastatin; Swine; Time Factors | 2010 |
Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management.
Topics: Adult; Atorvastatin; Colchicine; Critical Care; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Overdose; Female; Heptanoic Acids; Humans; Multiple Organ Failure; Propofol; Pyrroles; Rhabdomyolysis | 2010 |
Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Drug Interactions; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis | 2010 |
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticholesteremic Agents; Antifungal Agents; Atorvastatin; Coronary Artery Bypass, Off-Pump; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluconazole; Heptanoic Acids; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Postoperative Complications; Pyrroles; Rhabdomyolysis | 2011 |
Hypernatremia due to rhabdomyolysis in a patient on statin.
Topics: Anterior Wall Myocardial Infarction; Atorvastatin; Creatine Kinase, MB Form; Creatinine; Fatal Outcome; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypernatremia; Male; Middle Aged; Peritoneal Dialysis; Pyrroles; Rhabdomyolysis | 2011 |
Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction.
Topics: Aged; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Pyrazines; Pyrroles; Rhabdomyolysis; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Sorafenib: muscle wasting.
Topics: Benzamides; Benzenesulfonates; Humans; Imatinib Mesylate; Indoles; Muscle, Skeletal; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Rhabdomyolysis; Sorafenib; Sunitinib | 2011 |
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.
Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin | 2012 |
Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
Topics: Atorvastatin; Comorbidity; Dermatomyositis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis | 2012 |
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Genetic Predisposition to Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pantoprazole; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Pyrroles; Renal Dialysis; Rhabdomyolysis; Risk Factors; Treatment Outcome | 2012 |
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections | 2013 |
Severe colchicine intoxication in a renal transplant recipient on cyclosporine.
Topics: Acute Kidney Injury; Atorvastatin; Colchicine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrroles; Quadriplegia; Rhabdomyolysis; Treatment Outcome | 2012 |
Rhabdomyolysis with concurrent atorvastatin and diltiazem.
Topics: Acute Disease; Acute Kidney Injury; Atorvastatin; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis | 2002 |
The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
Topics: Atorvastatin; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Muscular Diseases; Myositis; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin | 2002 |
Efficacy and safety of atorvastatin after pediatric heart transplantation.
Topics: Adolescent; Atorvastatin; Child; Female; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Postoperative Period; Pyrroles; Retrospective Studies; Rhabdomyolysis | 2002 |
Muscular adverse effects of statins.
Topics: Anticholesteremic Agents; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Pravastatin; Pyridines; Pyrroles; Rhabdomyolysis; Simvastatin | 2003 |
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility.
Topics: Atorvastatin; Cholinesterase Inhibitors; Disease Susceptibility; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Malignant Hyperthermia; Middle Aged; Pain; Pyrroles; Rhabdomyolysis | 2003 |
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.
Topics: Atorvastatin; Clarithromycin; Drug Interactions; Esomeprazole; Female; Heart Block; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Rhabdomyolysis | 2003 |
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
Topics: Adult; Anti-Bacterial Agents; Atorvastatin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lopinavir; Male; Pyrimidinones; Pyrroles; Rhabdomyolysis; Ritonavir | 2003 |
Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Drug Evaluation; Heptanoic Acids; Humans; Hypertension; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin; Stroke; Treatment Outcome | 2003 |
Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Colon; Colonoscopy; Cyclosporine; Cytomegalovirus Infections; Drug Interactions; Heart Transplantation; Heptanoic Acids; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrroles; Rhabdomyolysis; Treatment Outcome | 2004 |
Formulary conversion programs: the need for patient-specific risk assessment.
Topics: Aged; Atorvastatin; Cyclosporine; Drug Interactions; Female; Formularies as Topic; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Postoperative Care; Pyrroles; Rhabdomyolysis; Risk Assessment; Simvastatin | 2004 |
The grapefruit challenge: the juice inhibits a crucial enzyme, with possibly fatal consequences.
Topics: Anticholesteremic Agents; Atorvastatin; Beverages; Citrus paradisi; Food-Drug Interactions; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; Rhabdomyolysis | 2004 |
Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
Topics: Antifungal Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Fatal Outcome; Fluconazole; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mycoses; Pyrroles; Rhabdomyolysis | 2005 |
Exertion-induced rhabdomyolysis in a patient on statin therapy.
Topics: Acute Kidney Injury; Atorvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hyperlipidemias; Long-Term Care; Male; Middle Aged; Physical Exertion; Pyrroles; Rhabdomyolysis; Risk Assessment; Severity of Illness Index | 2005 |
Intensive lipid lowering with atorvastatin in coronary disease.
Topics: Atorvastatin; Cardiovascular Diseases; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mortality; Pyrroles; Rhabdomyolysis | 2005 |
How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biomarkers; Creatine Kinase; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Middle Aged; Pravastatin; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States | 2005 |
Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation.
Topics: Acute Kidney Injury; Anticholesteremic Agents; Atorvastatin; Disseminated Intravascular Coagulation; Drug Synergism; Female; Hemolytic-Uremic Syndrome; Heptanoic Acids; Humans; Middle Aged; Muscle Relaxants, Central; Pyrroles; Quinine; Rhabdomyolysis; Sleep-Wake Transition Disorders | 2006 |
Media report of rare rhabdomyolysis cases seems to have triggered reluctance among some New Zealanders to use statins.
Topics: Anticholesteremic Agents; Atorvastatin; Health Education; Health Knowledge, Attitudes, Practice; Heptanoic Acids; Humans; Hypercholesterolemia; Mass Media; New Zealand; Pyrroles; Rhabdomyolysis; Simvastatin | 2006 |
Atorvastatin for stroke prevention.
Topics: Atorvastatin; Cerebral Hemorrhage, Traumatic; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Muscular Diseases; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Stroke; Sulfonamides; Time Factors | 2006 |
Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study.
Topics: Action Potentials; Animals; Aquaporin 4; Atorvastatin; Body Weight; Chloride Channels; Dose-Response Relationship, Drug; Eating; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Kidney Diseases; Lipids; Male; Membrane Potentials; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle, Skeletal; Muscular Diseases; Myosin Heavy Chains; Organ Size; Pyrroles; Rats; Rats, Wistar; Rhabdomyolysis; Time Factors | 2006 |
Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Topics: Atorvastatin; Australia; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Rhabdomyolysis; Risk Factors; Simvastatin | 2006 |
Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Topics: Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Rhabdomyolysis; Risk Factors; Simvastatin | 2006 |
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Prescriptions; Drug Therapy, Combination; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver Diseases; Lovastatin; Niacin; Pravastatin; Prevalence; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States; United States Food and Drug Administration | 2007 |
Atorvastatin-induced early-onset rhabdomyolysis in a patient with nephrotic syndrome.
Topics: Adolescent; Atorvastatin; Early Diagnosis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Male; Nephrotic Syndrome; Pyrroles; Rhabdomyolysis | 2007 |
Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
Topics: Atorvastatin; Biomarkers; Creatine Kinase, MM Form; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pain; Pyrroles; Randomized Controlled Trials as Topic; Rhabdomyolysis | 2007 |
[Rhabdomyolysis associated to combined ezetimibe-statin treatment].
Topics: Adult; Alcohol Drinking; Anticholesteremic Agents; Atorvastatin; Azetidines; Drug Therapy, Combination; Ezetimibe; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Time Factors | 2007 |
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Atorvastatin; Child; Child, Preschool; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Infant; Male; Middle Aged; Pravastatin; Pyridines; Pyrroles; Retrospective Studies; Rhabdomyolysis; Simvastatin; United States; United States Food and Drug Administration | 2008 |
Rhabdomyolysis after taking atorvastatin with gemfibrozil.
Topics: Adult; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Female; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hypertriglyceridemia; Hypolipidemic Agents; Pyrroles; Rhabdomyolysis | 1998 |
Judicious evaluation of adverse drug reactions: inaccurate assessment of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced muscle injury.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Atorvastatin; Diagnostic Errors; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pyrroles; Rhabdomyolysis; Simvastatin | 1999 |
Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
Topics: Anticholesteremic Agents; Atorvastatin; Cadaver; Clinical Enzyme Tests; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Pyrroles; Rhabdomyolysis | 1999 |
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Prospective Studies; Pyrroles; Rhabdomyolysis; Simvastatin; Triglycerides | 1999 |
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Topics: Acute Disease; Aged; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Atorvastatin; Drug Therapy, Combination; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Surgical Wound Infection; Tibial Arteries | 2000 |
. . . from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Topics: Anti-HIV Agents; Anti-Infective Agents; Antineoplastic Agents; Atorvastatin; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Heptanoic Acids; HIV Infections; Humans; Pyrroles; Rhabdomyolysis | 2000 |
Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
Topics: Acute Kidney Injury; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delavirdine; Drug Interactions; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mixed Function Oxygenases; Pyrroles; Rhabdomyolysis | 2002 |